Subscribe To

Price Alert Latest News Economic Calendar News

LUCD / Lucid Diagnostics to Present at 22nd Annual Needham Virtual Healthcare Conference

NEW YORK, April 17, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), today announced that Dr. Lishan Aklog, Chairman and Chief Executive Officer; and Dennis McGrath, Chief Financial Officer will present at the 22nd Annual Needham Healthcare Conference on Thursday, April 20, 2023 at 11:00 AM ET. Read More

Demo Live Account See Partner Details

Content Topics

Lucid

Diagnostics

Present

22nd

Annual

Needham

Virtual

Healthcare

Conference

Stock

LUCD

Posted: Apr 17 2023, 21:45

Author Name: PRNewsWire

LUCD News

By PRNewsWire
November 2, 2023

Lucid Diagnostics to Present at Canaccord Genuity Medtech, Diagnostics, and Digital Health & Services Forum

Lishan Aklog, M.D., Chairman & CEO, to Present November 16, 2023, in New York NEW YORK , Nov. 2, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq

By Seeking Alpha
August 15, 2023

Lucid Diagnostics Inc. (LUCD) Q2 2023 Earnings Call Transcript

Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q2 2023 Results Conference Call August 15, 2023 8:30 AM ET Company Participants Michael Parks - VP, IR Lishan Ak

By Seeking Alpha
May 16, 2023

Lucid Diagnostics Inc. (LUCD) Q1 2023 Earnings Call Transcript

Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q1 2023 Results Conference Call May 16, 2023 8:30 AM ET Company Participants Michael Parks - VP, IR Dr. Lishan A

By PRNewsWire
April 17, 2023

Lucid Diagnostics to Present at 22nd Annual Needham Virtual Healthcare Conference

NEW YORK, April 17, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medica

By CNBC
March 28, 2023

Lucid to cut 1,300 workers amid signs of flagging demand for its EVs

Lucid CEO Peter Rawlinson said the job cuts will hit "nearly every organization and level, including executives."

By Seeking Alpha
March 14, 2023

Lucid Diagnostics Inc. (LUCD) Q4 2022 Earnings Call Transcript

Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q4 2022 Earnings Conference Call March 14, 2023 8:30 AM ET Company Participants Michael Parks - Vice President,

By Seeking Alpha
November 14, 2022

Lucid Diagnostics Inc. (LUCD) Q3 2022 Earnings Call Transcript

Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Adrian Miller - Vice Presiden

By Seeking Alpha
May 11, 2022

Lucid Diagnostics' (LUCD) CEO Lishan Aklog on Q1 2022 Results - Earnings Call Transcript

Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Adrian Miller – Vice President-I

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.